What is the appropriate first‑trimester antenatal management for a pregnant woman?

First-Trimester Antenatal Management

All women of reproductive age capable of becoming pregnant should begin folic acid supplementation at 400 µg (0.4 mg) daily before conception and continue through the first trimester, with higher-risk women requiring 4-5 mg daily. 1

Preconception and Early First-Trimester Interventions

Folic Acid Supplementation (Critical Timing)

• Standard-risk women: 400 µg (0.4 mg) daily starting at least 1 month before conception 1
• High-risk women (BMI ≥30 kg/m², diabetes, prior neural tube defect, first-degree relative with NTD, or on antiepileptic drugs): 4-5 mg daily starting 1-3 months before conception 1, 2
• Neural tube closure occurs within 28 days after conception—supplementation must begin preconceptionally, as starting after a positive pregnancy test is too late 1, 2
• Food fortification alone (140 µg per 100g grain) reduced spina bifida by 31% and anencephaly by 16%, but is insufficient for complete prevention 1

Additional Micronutrient Supplementation

• Daily multivitamin containing: iron (45-60 mg elemental), zinc (8-15 mg), copper (2 mg), selenium (50 µg), thiamine (>12 mg), vitamin E (15 mg), and beta-carotene (not retinol vitamin A due to teratogenicity risk) 1, 2
• Vitamin D supplementation if deficient or post-bariatric surgery 1
• Calcium: 1,200-1,500 mg daily in divided doses, separated from iron by at least 2 hours 2

Immunization Status

• Update hepatitis B, rubella, varicella, Tdap, HPV, and influenza vaccines as needed before conception 1
• Screen for rubella seronegativity and vaccinate if indicated 1

Initial First-Trimester Visit (Ideally <10 Weeks)

Laboratory Screening

• Complete blood count to assess for anemia 1, 3
• Blood type and Rh status 1
• Infectious disease screening: HIV, hepatitis B and C, syphilis, rubella immunity 1, 3
• Urinalysis and urine culture for asymptomatic bacteriuria 1
• Thyroid function testing (TSH) 1, 3
• Fasting glucose or early gestational diabetes screening for high-risk women (BMI >30, diabetes, PCOS) 1, 3
• Toxoplasmosis and cytomegalovirus serology (varies by regional guidelines) 3

Risk Assessment and History

• Genetic screening: Assess family history, ethnic background, and maternal age for chromosomal/genetic disorders; offer cystic fibrosis and other carrier screening as indicated 1
• Obstetric history: Document prior miscarriage, preterm birth, stillbirth, or neonatal death—only 36-73% of women with prior complications discuss this history during first ANC 1, 4
• Medical conditions: Screen for chronic illnesses (hypertension, diabetes, thyroid disease), depression, anxiety, and domestic violence 1
• Medication review: Identify and discontinue teratogenic agents (isotretinoin, warfarin, certain antiseizure medications) 1
• Environmental exposures: Assess workplace and home exposure to heavy metals, solvents, pesticides, and endocrine disruptors 1

Physical Examination

• BMI calculation from pre-pregnancy height and weight, documented at first prenatal visit 1
• Blood pressure using appropriate cuff size for BMI 1
• Baseline physical assessment including cardiovascular and thyroid examination 1

Aneuploidy Screening Options (11-14 Weeks)

First-Trimester Combined Screening

• Nuchal translucency (NT) measurement via transabdominal ultrasound (95% success rate) between 11-14 weeks 1
• Maternal serum markers: pregnancy-associated plasma protein A (PAPP-A) and free beta-hCG or intact hCG 1, 5
• Combined screening detects ~82-90% of Down syndrome at 5% false-positive rate 1
• NT measurement requires quality assurance certification and ongoing quality review due to inter/intra-observer variability 1

Alternative Screening Approaches

• Cell-free DNA screening may be offered as an alternative with comparable or superior detection rates 1
• Integrated screening (NT + PAPP-A in first trimester combined with quad screen in second trimester) offers highest sensitivity but delays results 1
• Women ≥35 years should continue to be offered diagnostic testing (CVS or amniocentesis) regardless of screening results 1

Important Counseling Points

• Maternal autonomy: Women should be informed of adjusted risks and allowed to make decisions based on individual risk/benefit assessment 6
• Women who decline further chromosomal information should not be required to undergo testing 6
• Isolated soft markers on ultrasound do not require diagnostic testing if prior screening was negative 1

Ultrasound Evaluation

Dating and Viability Assessment

• First ultrasound ideally performed at 11-14 weeks for accurate dating and NT measurement 1
• Avoid pulsed Doppler in first trimester when normal or potentially normal intrauterine pregnancy exists 1
• Document gestational sac location, yolk sac presence, embryo with crown-rump length, and cardiac activity 1, 5

Pregnancy of Unknown Location Management

• If no intrauterine gestational sac visible, obtain serial quantitative β-hCG every 48 hours 1, 5
• Viable intrauterine pregnancy: β-hCG increases ≥53% over 48 hours 5
• Ectopic pregnancy risk: β-hCG plateau (<15% change) or abnormal rise (10-53%) 5
• Traditional discriminatory threshold of 3,000 mIU/mL has no diagnostic utility (LR+ 0.8, LR- 1.1) 5
• 22% of ectopic pregnancies occur at β-hCG <1,000 mIU/mL—never defer ultrasound based on "low" β-hCG 5

Nutritional and Lifestyle Counseling

Dietary Guidance

• Nutritional counseling for all women, with dietitian referral for BMI >30 or <18.5 1
• Physical activity: 30 minutes of moderate exercise at least 5 days per week 1
• Gestational weight gain counseling based on pre-pregnancy BMI 1
• Avoid alcohol and tobacco completely 1

Special Populations

• Women with obesity (BMI ≥30): Early booking visit, anesthesia consultation if BMI >35, VTE risk assessment, 5 mg folic acid, early GDM screening 1
• Post-bariatric surgery: Additional monitoring of vitamin A, zinc, copper, selenium, vitamin D, calcium, phosphate, magnesium, and PTH every 6 months 1, 2

Timing and Frequency

Optimal Initiation

• First ANC visit should occur in the first trimester (≤12 weeks) 7, 8
• Early ANC initiation reduces miscarriage risk by 43% 8
• Women with timely first-trimester ANC have 5.2 times higher odds of receiving adequate ANC contacts and higher content of care 7
• Only 44-50% of women globally achieve timely first-trimester ANC initiation 7

Follow-up Schedule

• WHO 2016 guidelines recommend minimum of 8 ANC contacts throughout pregnancy, with first contact in first trimester 7
• Women with timely initiation have 4.7 times higher odds of achieving 8+ contacts 7

Critical Safety Considerations

Red Flags Requiring Immediate Evaluation

• First-trimester vaginal bleeding: Transvaginal ultrasound is reference standard and first-line diagnostic modality 1
• Severe nausea/vomiting: Assess for hyperemesis gravidarum; safe antiemetics available 9
• Abdominal pain with positive pregnancy test: Rule out ectopic pregnancy with ultrasound and serial β-hCG regardless of β-hCG level 5, 9
• Urinary symptoms: Screen and treat asymptomatic bacteriuria and UTIs promptly 9

Common Pitfalls to Avoid

• Do not wait for "missed period + 1 week" to initiate care—neural tube closure occurs by 28 days post-conception 1, 2
• Do not use retinol (preformed vitamin A)—use beta-carotene form only 2
• Do not rely on single β-hCG value to exclude ectopic pregnancy when ultrasound is indeterminate 5
• Do not defer ultrasound in symptomatic patients based on "low" β-hCG 5